The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Effects of Testosterone Treatment in Older Men
Open accessAbstract
BACKGROUND: Serum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established. METHODS: We assigned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive either testosterone gel or placebo gel for 1 year. Each man participated in one or more of three trials--the Sexual Function Trial, the Physical Function Trial, and the Vitality Trial. The primary outcome of each of the individual trials was also evaluated in all participants. RESULTS: Testosterone treatment increased serum testosterone levels to the mid-normal range for men 19 to 40 years of age. The increase in testosterone levels was associated with significantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P<0.001), as well as significantly increased sexual desire and erectile function. The percentage of men who had an increase of at least 50 m in the 6-minute walking distance did not differ significantly between the two study groups in the Physical Function Trial but did differ significantly when men in all three trials were included (20.5% of men who received testosterone vs. 12.6% of men who received placebo, P=0.003). Testosterone had no significant benefit with respect to vitality, as assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue scale, but men who received testosterone reported slightly better mood and lower severity of depressive symptoms than those who received placebo. The rates of adverse events were similar in the two groups. CONCLUSIONS: In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years of age had a moderate benefit with respect to sexual function and some benefit with respect to mood and depressive symptoms but no benefit with respect to vitality or walking distance. The number of participants was too few to draw conclusions about the risks of testosterone treatment. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00799617.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“there is accumulating evidence against a link between testosterone therapy and prostate cancer development.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the ‘Testosterone Trials’, treatment with testosterone improved participants’ results in the 6 min walk test compared with placebo (20.5% versus 12.6%; P = 0.003)53.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Randomized controlled trials have shown that there is not a significant increase in the rate of a prostate cancer diagnosis in older, testosterone deficient men who were treated with testosterone compared to placebo.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In trials, patients with low testosterone have demonstrated statistically significant improvements in erectile function, 24 sex drive, 24 anemia, 25 bone mineral density, 26 lean body mass, 27 and depressive symptoms. 24”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
In the citing paper
“Testosterone supplementation is also shown to benefit other aspects of health, including sexual function, physical function, vitality, quality of life and improved mood [109, 111].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [111]
In the citing paper
“Of note, potential improvements in muscle (and lean) mass may not directly result in improved muscle function214,215.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [214]
In the citing paper
“In the large T Trials, sexual function improved modestly with testosterone treatment,”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [37]
In the citing paper
“suggesting that even older men with a relatively high comorbid burden (37% had diabetes and 15% a previous myocardial infarction) can respond to testosterone.37”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [37]
In the citing paper
“In the Testosterone Trials of stringently selected symptomatic men with a baseline testosterone averaging < 9.5 nmol/L (275 ng/dL) for no apparent reason other than age, testosterone treatment had a modest benefit in sexual function, and some benefit with respect to mood and depressive symptoms (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In an intensive lifestyle randomized controlled trial (RCT) of relatively healthy obese middle-aged men, 15% weight loss increased the mean International Index of Erectile Function (IIEF) score by 3.10, which is clinically meaningful (23) and similar to the increase of 2.64 reported in the Testosterone Trials, although those men were older (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“Although head-to-head studies are lacking, the efficacy reported for PDE5 inhibitors is greater than that reported for lifestyle intervention and testosterone treatment (15, 25).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In RCTs of middle-aged and older men, where contraindications have been rigorously excluded and treatment was carefully monitored, short-term testosterone treatment has been associated with a low risk of adverse events (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“Although the trial was too small to reliably assess testosterone treatment-associated risks (15)”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“it does provide some assurance about the potential relative short-term safety of testosterone treatment in men without the previously mentioned contraindications.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“These guideline recommendations are consistent with the exclusion criteria specified in the Testosterone Trials (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In the 12-month Testosterone Trials, the rates of adverse events were similar in the testosterone- and placebo-treated men.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Terza, J. V., Basu, A., & Rathouz, P. J. (2008) · Journal of Health Economics · doi:10.1016/j.jhealeco.2007.09.009 · Cited by 1,728
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationThe International Index of Erectile Function (IIEF): a state-of-the-science review
Rosen, R., Cappelleri, J. C., & Gendrano, N. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900857 · Cited by 1,050
Self-citationRedelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
Flagged first, then by citations
2 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ware J, Kosinski M. SF-36 Physical and Mental Health Summary Scales: a manual for users of Version 1, Second Edition. Lincoln, RI: Quality Metric, 2005.
Cited by
Sorted by citations
Items 701–800 of 891
Inder, W. J., & Grossmann, M. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad100 · Cited by 1
Testosterone for Middle-Aged and Older Men with Hypogonadism
Jiesisibieke, Z. L., & Schooling, C. M. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2512879 · Cited by 1
Testosteron für schwache Senioren?
Füeßl, H. S. (2016) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-016-8378-7
Testosteron für schwache Senioren?
hsf (2016) · Heilberufe · doi:10.1007/s00058-016-2263-8
Re: Effects of Testosterone Treatment in Older Men
Rai, S., Scovell, J. M., Palmer, J., & Ramasamy, R. (2016) · European Urology · doi:10.1016/j.eururo.2016.06.029
El doctor Pío Baroja y Nessi, un intelectual con síndrome de fragilidad
Arámbarri, J. M., & de la Torre, A. E. (2016) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2016.08.004
Improving the management of testosterone deficiency
Mayor, S. (2016) · Prescriber · doi:10.1002/psb.1506 · Cited by 1
O uso de suplementação de testosterona em homens e mulheres
Gun, S., & Neto, L. F. D. S. (2016) · Revista da Faculdade de Ciências Médicas de Sorocaba · doi:10.5327/z1984-4840201628923
Rastrelli, G., & Maggi, M. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_32-1
Obesity and Aging in Late-Onset Hypogonadism
Rastrelli, G., & Wu, F. C. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_17
Benefits and Adverses Effects of Testosterone Therapy
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_13
Testosteronmangel beim alternden Mann
Freystaetter, G., & Bischoff-Ferrari, H. A. (2017) · Praxis · doi:10.1024/1661-8157/a002705
Brito, M. M. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2017.tde-24042017-173840
Meta-Epidemiology of Testosterone’s Risks and Benefits—Will We Ever Know the Answer?—Reply
Cheetham, T. C., Eeden, S. K. V. D., & Jacobsen, S. J. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2964
The blue pill (sildenafil) and its descendants: an overview
Krzanowski, T., Dąbkowska, L., Wujec, M., & Kędzierska, E. (2017) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2017-0023
Yuen, F., Wang, C., & Swerdloff, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64556-7
Self-citationTestosteron – Benzin für den Mann?
Randazzo, M. (2018) · Journal für Urologie und Urogynäkologie/Österreich · doi:10.1007/s41973-018-0021-z
Testosterone Therapy: a Panacea for Sexual Dysfunction in Men?
Helo, S., Thomas, P., & Tadros, N. N. (2018) · Current Sexual Health Reports · doi:10.1007/s11930-018-0151-8
Testosterone therapy and physical function
Anawalt, B. D., & Page, S. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30202-x
Esteroides anabolizantes androgênicos: mecanismos de ação e possíveis efeitos colaterais
Loschi, R., & Ide, B. N. (2018) · Revista Brasileira de Nutrição Funcional · doi:10.32809/2176-4522.41.76.2
Zum Beitrag: Hormonersatztherapie des Mannes
Kentsch, M. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0754-8311
Sotirov, S., Penev, P., & Kirova, D. G. (1989) · PubMed
Bei Testosteronmangel weiter nachforschen!
Meißner, T. (2019) · CME · doi:10.1007/s11298-019-7209-4
Androgen receptor expression and steroid action in bone
Krishnan, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00041-5
Sex Steroid Hormones and Osteosarcopenia
Girgis, C. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-25890-0_8
Is testosterone replacement therapy an effective treatment of erectile dysfunction?
Covey, C. J., & Roberts, W. A. (2020) · Evidence-Based Practice · doi:10.1097/ebp.0000000000000745
Hormone replacement therapy in patients with a history of cancer
Левченко, Н. Е., Efremov, E. A., Владимировна, К. Е., Sidorenko, Y. S., Melnik, Y. I., & Koryakin, A. V. (2019) · Practical oncology · doi:10.31917/2004310
Kolenburg, J., & de Vries, P. (2020) · Tijdschrift voor Urologie · doi:10.1007/s13629-020-00292-w
Reincke, M., & Lehnert, H. (2020) · Der Internist · doi:10.1007/s00108-020-00797-x
Kotler, J. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Clinical Trials for Erectile Dysfunction in Parkinson’s Disease
Lim, S., Tan, A. H., & Grossmann, M. (2020) · Neuromethods · doi:10.1007/978-1-0716-0912-5_14
Interview with Dr. Abraham Morgentaler
Traish, A. M., & Morgentaler, A. (2020) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.29000.int
Mental Health of Men in Later Life
Almeida, O. P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108646765.024
Testosterone levels in COVID‐19: More data, but how do we proceed?
Patoulias, D., & Patoulias, I. (2021) · Andrologia · doi:10.1111/and.14088
Elgendy, H., Hassan, W., Alnadhari, I., Shamsodini, A., & Ansari, A. A. (2021) · Research Square · doi:10.21203/rs.3.rs-457922/v1
Understanding the Controversy Regarding Treatment of Age-Related Testosterone Deficiency
Morgentaler, A. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0006
Zitzmann, M. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0016
Testosterone and Prostate Effects
Salter, C. A., & Mulhall, J. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_7
Erythrocytosis in Patients on Testosterone Therapy
Desai, A. P., & Go, R. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_2
Déficit en testostérone. Quels bénéfices et risques et pour quels patients ?
Faix, A., Cuzin, B., Desvaux, P., Huyghe, É., Lejeune, H., Almond, T., & Burte, C. (2021) · Sexologies · doi:10.1016/j.sexol.2021.06.003
Неспецифический реактивный гепатит у больных желчнокаменной болезнью
Бычков, С. А. (2007) · Electronic Kharkiv National University Institutional Repository (Kharkiv National University)
Peng, R., Dai, W., Li, D., & Li, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-1130484/v1
Saad, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_9
Bahat, G., & Erdoğan, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_541
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
Self-citationHypothalamo–Pituitary–Testicular Axis Function in Systemic Diseases and Effects of Medications
Wittert, G., Yeap, B. B., & Grossmann, M. (2022) · doi:10.1093/med/9780198870197.003.0492
Yang, H., Ho, C., Zhao, P. T., Su, D., & Seftel, A. D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-4928-1_12
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Dominguez, L. J., & Barbagallo, M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch115
Bahat, G., & Erdoğan, T. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_541-1
Hormone Replacement Therapy in Men
Pham, C. H., Wang, C., & Swerdloff, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99449-2
Self-citationFaculty Opinions recommendation of Treatment of men for "low testosterone": A systematic review.
Minhas, S., Tharakan, T., & Miah, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726764636.793556540
Cnattingius, S., Haller, D., Snyder, P. J., & Nevitt, M. (2016) · British Journal of Hospital Medicine · doi:10.12968/hmed.2016.77.3.128
Self-citation(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-802629-8.16001-2
Testosterone replacement therapy in older men: results of the T-Trials
(2019) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2019.000028
Bahat, G., & Erdoğan, T. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_541-2
Hypogonadism and Testosterone Therapy in Elderly Men
Yeap, B. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66168-8
Confidentiality Issues Relating to the Data Monitoring Committee
Ellenberg, S. S., Fleming, T. R., & DeMets, D. L. (2019) · doi:10.1002/9781119512684.ch5
Self-citationNangia, A. K. (2017) · Urology · doi:10.1016/j.urology.2016.12.067
Minhas, S., Miah, S., & Tharakan, T. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735112639.793556659
Bahat, G., & Erdoğan, T. (2021) · Springer eBooks · doi:10.1007/978-3-319-69892-2_541-3
Testosterone kinetics on hypogonadal men under clomiphene
Silva, É. D., da Silva, M. M., Moretti, T. B. C., Andrade, D. L., Avilez, N. D., & Reis, L. O. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03230-4 · Cited by 1
Faut-il traiter l’andropause ? si oui, comment ?
Burte, C. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.05.007
Benefits and Risks of Testosterone Replacement in the Older Man with Hypogonadism
Marcelli, M., & Mediwala, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_30
Störungen der Erektion, Kohabitation und Ejakulation
Soave, A., & Kliesch, S. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_30-1
The Role of Post-Radical Prostatectomy Testosterone Therapy in Erectile Function Recovery
Huynh, L. M., Gevorkyan, R., & Ahlering, T. E. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0005
Wu, F. C. W., & Huhtaniemi, I. T. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09761-6
Contraceptive Advice for Trans Male Persons
Gava, G., Mancini, I., & Meriggiola, M. C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108899987.028
THE SENSITIVE PLANT MIMOSA PUDICA: ASPIRATION OF SEXUAL MOTIVATION
(2022) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2023/12.1.6784
Testosterone Deficiency in the Older Male
Ahmad, D. S., & Mahmood, D. F. (2022) · SAS Journal of Medicine · doi:10.36347/sasjm.2022.v08i12.006
Chapter 2. Physiological and Clinical Considerations of Geriatric Patient Care
Jaeger, J., & Kuchel, G. A. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds02
Bacocina, R. C., Marques, I. S., Kawamoto, A. B. S. S., de Carvalho, W. V., Katakura, E. A. L. B., & Alarcon, M. F. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c19
Monteiro, P. N. C., Chaves, M. S. R. S., Lima, C. D. A., Santos, J. D. S., Carvalho, A. R., Moreira, W. D. S., & Ferreira, L. G. D. F. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c3
FIBROMIALGIA: ASPECTOS CLÍNICOS E SUA IMPLICAÇÃO NA VIDA DOS PACIENTES – UMA REVISÃO DE LITERATURA
Taveira, A. C. S., Alves, A. C. D. S., da Silva, B. D. F., Alves, G. C., Lins, J. M. F. B., Lima, L. A., Alves, M. G. C., Dias, T. S., & da Costa, A. W. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c11
OBESIDADE SARCOPÊNICA: UM NOVO DESAFIO
de Queiroga, V. M., & Chaves, T. C. S. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c14
Sartori, I. F. G., Arossi, G. A., & Hirdes, A. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c22
OZONIOTERAPIA NO TRATAMENTO DE DOENÇAS INFLAMATÓRIAS CRÔNICAS: REVISÃO BIBLIOGRÁFICA
Ferreira, D. B. M., & Moura, M. L. V. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c16
DIAGNÓSTICO E TERAPÊUTICA DA TUBERCULOSE INFANTIL
Vasconcelos, A. F., da Silva, A. A., Terto, W. D. D. S., Calaça, M. B., da Silva, F. P. M., Rocha, F. V. T., de Sousa, A. C., de Oliveira, E. V., Madureira, G. N., dos Santos, B. S. P., et al. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c25
TUMOR GLIONEURAL DIFUSO LEPTOMENÍNGEO
de Queiroga, V. M. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c23
Monteiro, P. N. C., Sousa, C. E. D. S., Chaves, M. S. R. S., Lima, C. D. A., Santos, J. D. S., Carvalho, A. R., Moreira, W. D. S., da Silva, E., & Ferreira, L. G. D. F. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c9 · Cited by 1
BULLYING NAS ESCOLAS: MANIFESTAÇÕES E SUAS CONSEQUÊNCIAS
de Sousa, F. M. A., de Sousa, K. A., Albuquerque, V. V., & Gomes, G. B. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c5
ANÁLISE DOS TONS DE CINZA EM IMAGENS DE SUBTRAÇÃO RADIOGRÁFICA PARA DETECÇÃO DE PERDA ÓSSEA
Cabau, L., Lima, A. F. D. S., Auresco, F. N., Gava, F., Matheus, R. A., & Queiroz, P. M. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c2
Lopes, L. C. A., Amorim, F. A., Sá, N. S., Lima, T. D. S. S., Sá, W. S., Cardoso, A. C. R. B., & Goncalves, E. M. D. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c4
FATORES QUE INFLUENCIAM NA ESCOLHA DA VIA DE PARTO: UMA REVISÃO DE LITERATURA
do Nascimento, B. T. S., da Costa, K. L., Muniz, K. M. H., Schuler, M. F. D. L., Costa, Y. F. D. A., de Oliveira, S. D., & do Nascimento, I. T. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c10 · Cited by 2
A IMPORTÂNCIA DO ALEITAMENTO MATERNO PARA O SISTEMA IMUNOLÓGICO: REVISÃO BIBLIOGRÁFICA
Júnior, E. L. D. S., & Gonzalez, L. F. C. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c1
SÍNDROME DE NOONAN: UM RELATO DE CASO
de Queiroga, V. M. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c21
IMPACTOS DA TV E DA INTERNET NO COMPORTAMENTO INFANTIL: UMA REVISÃO DA LITERATURA BRASILEIRA
de Andrade, R. R., & Prado, R. D. C. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c13
REVISÃO NARRATIVA SOBRE O PAPEL DO ENFERMEIRO FRENTE À DOENÇA HIPERTENSIVA ESPECÍFICA DA GRAVIDEZ
da Silva, M. L., Coelho, A. A. D. S., Silva, E. P., da Conceição, I. M. P., Miguel, J. L. P., & do Nascimento, R. C. M. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c20
EFEITO DAS SAPONINAS SOBRE A MICROBIOTA INTESTINAL DE PACIENTES COM SÍNDROME METABÓLICA
dos Santos, L. C., Costa, D. D. D. M., Lima, D. D. O., Batista, C. C., dos Santos, K. E., Moreira-Araújo, R. S. D. R., Brandão, A. D. C. A. S., da Silva, R. A., & Martins, M. D. C. D. C. E. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c8
CORRELATOS ENTRE NOMOFOBIA E DEPENDÊNCIA DE SMARTPHONE
da Cunha, L. R. L., Santos, L. B., dos Santos, Z. C., da Silva, P. G. N., SOUSA, Í. M., de Araújo, G. R., Araújo, R. S. E., dos Santos, L. P., Silva, T. C., & de Medeiros, É. D. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c6
DORES CRÔNICAS E A TERAPIA COMPORTAMENTAL: REVISÃO INTEGRATIVA
da Costa, L. N. X., César, V. S., de Sousa, F. M. A., Albuquerque, V. V., Ferreira, M. E. C., Albuquerque, F. B. D. C., Vicente, L. Í., & Prado, R. D. C. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c7 · Cited by 1
PERFIL EPIDEMIOLÓGICO DE ÓBITOS MATERNOS NO ESTADO DO PIAUÍ ENTRE 2018 A 2020
Almeida, A. B. D. C., Guedes, R. D. Q. F., da Silva, M. E. V. L., de Sousa, G. P., Ruiz, M. S., de Oliveira, M. G. F. U., de Sousa, O. M. C., Silva, M. Y. S., Silva, E. V. S. E., & de Araújo, M. F. O. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c17
Morais, C. D. A., Filho, F. J. D. A., Carneiro, F. A., de Oliveira, J. X., Gurgel, L. L., Linhares, L. J. P., & Linhares, F. J. D. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c18
HANSENÍASE EM MENORES DE QUINZE ANOS NO BRASIL: ASPECTOS SÓCIO DEMOGRÁFICOS, CLÍNICOS E OPERACIONAIS
Almeida, P. D., Ribeiro, U. K. D. S., Candido, S. C. N., & Filho, A. C. A. D. A. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128c12
Testosterone Therapy in Oncologic Patients
Solsrud, E., Louters, M. M., & Pearlman, A. M. (2023) · Current Sexual Health Reports · doi:10.1007/s11930-022-00351-w
Benefits of Testosterone Replacement and Methods of Substitution
Ho, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109345
Seneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_25-1
Andropause – gibt es das überhaupt?
Zitzmann, M. (2023) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-023-00306-x
Seneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_25
Metadata
- Authors
- Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., Ensrud, K. E., Lewis, C. E., Farrar, J. T., Cella, D., Rosen, R. C., Pahor, M., Crandall, J. P., Molitch, M. E., Cifelli, D., Dougar, D., Fluharty, L., Resnick, S. M., Storer, T. W., Anton, S., Basaria, S., Diem, S. J., Hou, X., Mohler, E. R., Parsons, J. K., Wenger, N. K., Zeldow, B., Landis, J. R., & Ellenberg, S. S.
- Affiliations
- University of Pennsylvania (US)
- Brigham and Women's Hospital (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- From the Division of Endocrinology, Diabetes, and Metabolism (P.J.S.), the Department of Biostatistics and Epidemiology (A.J.S.-S., J.T.F., X.H., B.Z., J.R.L., S.S.E.), the Center for Clinical Epidemiology and Biostatistics (D. Cifelli, D.D., L.F.), and the Division of Cardiovascular Disease, Section of Vascular Medicine, Department of Medicine (E.R.M.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Research Program in Men’s Health: Aging and Metabolism, Brigham and Women’s...
- University of Pittsburgh (US)
- Yale University (US)
- University of California San Diego (US)
- The Lundquist Institute (US)
- University of Minnesota (US)
- Northwestern University (US)
- New England Research Institutes (US)
- University of Florida (US)
- Albert Einstein College of Medicine (US)
- National Institutes of Health (US)
- Emory University (US)
- ORCID
- Snyder, Peter J.
- Bhasin, Shalender
- Cunningham, Glenn R.
- Matsumoto, Alvin M.
- Cauley, Jane A.
- Gill, Thomas M.
- Barrett-Connor, Elizabeth
- Swerdloff, Ronald S.
- Wang, Christina
- Ensrud, Kristine E.
- Lewis, Cora E.
- Farrar, John T.
- Cella, David
- Crandall, Jill P.
- Molitch, Mark E.
- Resnick, Susan M.
- Storer, Thomas W.
- Anton, Stephen
- Basaria, Shehzad
- Diem, Susan J.
- Hou, Xiaoling
- Parsons, J. Kellogg
- Wenger, Nanette K.
- Zeldow, Bret
- Landis, J. Richard
- Ellenberg, Susan S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-02-18
- Volume
- 374
- Issue
- 7
- Pages
- 611-624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5209754
- OpenAlex
- W2324158400
- Cited by
- 890
- References
- 40
- Citations by year
- 2026: 49 · 2025: 73 · 2024: 73 · 2023: 97 · 2022: 79 · 2021: 65 · 2020: 81 · 2019: 76 · 2018: 103 · 2017: 106 · 2016: 86
- FWCI
- 124.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p60dk079626-05, UL1TR000142)
- National Institute on Aging (U01AG030644, P30-AG013679, R01AG037679, K24AG021507, K07AG043587, R01 AG37679, P30AG024827, P30AG028740, P30AG021342)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK079626, P60-DK-079626, P30DK079626)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- testosterone replacement therapy, older men, hypogonadism, testosterone gel, sexual function, erectile function, sexual desire, physical function, walking distance, vitality, depressive symptoms, mood, adverse events
- MeSH terms
- Aged, Depression, Double-Blind Method, Fatigue, Humans, Libido, Male, Reference Values, Sexual Behavior, Testosterone, Walking, Prostate-Specific Antigen, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
